Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

2.0K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.0K
Abnormal Proliferation02:23

Abnormal Proliferation

4.4K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.4K
Drugs that Destabilize Microtubules01:10

Drugs that Destabilize Microtubules

1.9K
Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
1.9K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.4K
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

5.7K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
5.7K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

4.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Cell autonomous inflammation in VEXAS is mediated by cGAS-STING.

bioRxiv : the preprint server for biology·2026
Same author

Clonal dynamics of germinal center refueling by secondary immunization.

bioRxiv : the preprint server for biology·2026
Same author

Replaying germinal center evolution on a quantified affinity landscape.

Cell·2026
Same author

Phosphoproteomic profiling reveals post-translational dysregulation in Huntington's disease patient-derived neurons.

Cellular & molecular biology letters·2026
Same author

Bound for the nucleus: defining the molecular principles of cargo selection by importin 9.

bioRxiv : the preprint server for biology·2026
Same author

Proteomic profiling of Elp1-deficient trigeminal ganglia reveals disruption of neurotrophic and metabolic pathways in a familial dysautonomia mouse model.

Developmental dynamics : an official publication of the American Association of Anatomists·2026
Same journal

Layered social competition coordinates reproductive hierarchy formation in ants.

bioRxiv : the preprint server for biology·2026
Same journal

Combination epigenetic-targeted therapy increases the immunogenicity of poorly immunogenic sarcomas.

bioRxiv : the preprint server for biology·2026
Same journal

Loss of LanC-like proteins delays post-injury regeneration of aging skeletal muscles.

bioRxiv : the preprint server for biology·2026
Same journal

Integrative Transfer Network: Deep Transfer Learning Across Populations and Prediction Targets.

bioRxiv : the preprint server for biology·2026
Same journal

Confidence-supported label-free metabolic imaging with FPhaS phase autofluorescence microscopy.

bioRxiv : the preprint server for biology·2026
Same journal

Sequence-encoded autoinhibition couples mRNA decapping activity to phase separation.

bioRxiv : the preprint server for biology·2026
查看所有相关文章

相关实验视频

Updated: May 16, 2025

Live Imaging to Study Microtubule Dynamic Instability in Taxane-resistant Breast Cancers
06:02

Live Imaging to Study Microtubule Dynamic Instability in Taxane-resistant Breast Cancers

Published on: February 20, 2017

7.5K

GMCL1 控制53BP1的稳定性,调节癌症中帕克利塔塞尔敏感性

Yuki Kito1,2, Tania J Gonza Lez-Robles1,3,4, Sharon Kaisari1,2,4

  • 1Department of Biochemistry and Molecular Pharmacology, New York University Grossman School of Medicine, New York, NY 10016, USA.

bioRxiv : the preprint server for biology
|April 1, 2025
PubMed
概括
此摘要是机器生成的。

高GMCL1表达通过降解53BP1驱动癌症中帕克利塔塞尔耐药性,防止线粒体计时器复合体的形成,促进细胞增殖. 抑制GMCL1可能会恢复分类体的敏感性.

关键词:
53BP1BP1是什么意思GMCL1 GMCL1 的使用方法线粒体的时间表是线粒体的时间表.在p53中,p53是什么?长时间的线粒分裂.蛋白质降解 蛋白质降解在任何地方都是无处不在的.

更多相关视频

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics
06:00

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics

Published on: May 14, 2016

11.0K
Long-term Live-cell Imaging to Assess Cell Fate in Response to Paclitaxel
08:29

Long-term Live-cell Imaging to Assess Cell Fate in Response to Paclitaxel

Published on: May 14, 2018

9.8K

相关实验视频

Last Updated: May 16, 2025

Live Imaging to Study Microtubule Dynamic Instability in Taxane-resistant Breast Cancers
06:02

Live Imaging to Study Microtubule Dynamic Instability in Taxane-resistant Breast Cancers

Published on: February 20, 2017

7.5K
Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics
06:00

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics

Published on: May 14, 2016

11.0K
Long-term Live-cell Imaging to Assess Cell Fate in Response to Paclitaxel
08:29

Long-term Live-cell Imaging to Assess Cell Fate in Response to Paclitaxel

Published on: May 14, 2018

9.8K

科学领域:

  • 细胞生物学 细胞生物学
  • 分子瘤学分子瘤学
  • 癌症治疗方法 癌症治疗方法

背景情况:

  • 线粒细胞监测通路 (MSP) 通常在长时间的M期中停止细胞分裂,涉及53BP1,USP28和p53复合体.
  • 癌症中帕克利塔塞尔耐药性涉及绕过MSP,但机制尚不清楚.
  • 了解耐药性对于有效的癌症治疗至关重要.

研究的目的:

  • 研究癌症中帕克利塔克塞尔耐药性背后的机制.
  • 识别新的治疗点,以克服对标的抗性.

主要方法:

  • 蛋白相互作用研究分析53BP1和GMCL1结合.
  • 乌比基酸酶试验以确定CRL3GMCL1在53BP1.1上的活性.
  • 在各种癌症细胞系中,对GMCL1表达与帕克利塔塞尔耐药性的相关性分析.
  • 功能性研究评估了GMCL1损失对药物敏感性的影响.

主要成果:

  • 53BP1直接与GMCL1相互作用,而CRL3GMCL1的目标是53BP1在M阶段降解.
  • 高GMCL1表达与p53野生型癌症 (子宫内膜,乳腺,上空消化道) 的帕克利塔塞尔耐药性相关.
  • 在表达p53的细胞中,GMCL1的枯竭恢复了帕克利塔塞尔的敏感性.

结论:

  • GMCL1通过调解53BP1降解,抑制线粒体计时器综合体,并允许p53降解来促进帕克利塔塞尔耐药性.
  • GMCL1 是一种潜在的治疗点,可以使得对纳税素耐药的癌症重新敏感.